Found 97 matching trials
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma PHASE2 Background:
One way to treat liver cancer is to deliver chemotherapy drugs...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
A Single-arm, Open-label, Prospective Clinical Study of Surufatinib Combined With Immunotherapy and Chemotherapy for Unresectable or Metastatic Biliary Tract Cancer. PHASE2 This is a single-arm, open-label, prospective clinical study aimed at obser...
Show More Location
Multiple Locations
Learn More & Join Trial
HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT) PHASE2 Patients with intrahepatic cholangiocarcinoma (IHC) have relatively aggress...
Show More Location
Oslo University Hospital
Learn More & Join Trial
A Phase II Study of Adjuvant Durvalumab Combined With GEMOX/GC Chemotherapy Followed by Lenvatinib Versus Capecitabine in Biliary Tract Cancer. PHASE2 This study is designed as a prospective, randomized, open-label, phase II c...
Show More Location
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH), Beijing, 100730
Learn More & Join Trial
AZA Combined with R-GemOx for Elderly DLBCL Patients PHASE2 This is a prospective, single-arm, multicenter, phase II clinical trial to ...
Show More Location
Daping Hospital, Third Military Medical University (Army Medical University)
Learn More & Join Trial
Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage PHASE3 Purpose :To compare the efficacy and and safety of the P-Gemox chemotherapy...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma PHASE3 This is a multicenter, randomized, controlled, open-label Phase III clinica...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
Tislelizumab+Lenvatinib+Gemox Regiment for Potentially Resectable Locally Advanced Malignant Tumors of Biliary System. PHASE2 This is a single-arm, open, Phase II clinical study of Tislelizumab combine...
Show More Location
Tianjin Medical University Cancer Institute & Hospital
Learn More & Join Trial
Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma PHASE2 In patients with cholangiocarcinoma therapeutic effects have been reported ...
Show More Location
Technical University of Munich at the Klinikum rechts der Isar II. Medizinische Klinik Ismaninger Str. 22
Learn More & Join Trial
Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma PHASE3 This is a randomized, open label, multicenter phase III trial comparing the...
Show More Location
Moores UC San Diego Cancer Center
Learn More & Join Trial